Sanofi (SNW2) — Cash Flow Reinvestment Rate
Latest as of September 2025:
2.41x
Sanofi (SNW2) has a Cash Flow Reinvestment Rate of 2.41x as of September 2025, reinvesting €9.04 Billion (capex €0.00 plus investments €-9.04 Billion) from operating cash flow of €3.75 Billion. Check Sanofi cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
2.41x
(Capex + Investments) / Operating CF
Total Reinvested
€9.04 Billion
Capex + Investments
Operating Cash Flow
€3.75 Billion
EUR
Capital Expenditures
€0.00
EUR
Sanofi Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Sanofi across 9 annual periods. Explore SNW2 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Sanofi (2016–2024)
Year-by-year capital reinvestment analysis for Sanofi. For live market cap and broader valuation context, see SNW2 company net worth.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.84x | €7.60 Billion | €9.08 Billion | €3.19 Billion | ▼ -6.9% |
| 2023 | 0.90x | €9.22 Billion | €10.26 Billion | €3.02 Billion | ▲ +382.9% |
| 2022 | 0.19x | €1.96 Billion | €10.53 Billion | €1.61 Billion | ▲ +12.1% |
| 2021 | 0.17x | €1.75 Billion | €10.52 Billion | €1.48 Billion | ▼ -89.3% |
| 2020 | 1.55x | €11.49 Billion | €7.42 Billion | €1.25 Billion | ▲ +777.8% |
| 2019 | 0.18x | €1.36 Billion | €7.71 Billion | €1.32 Billion | ▼ -36.9% |
| 2018 | 0.28x | €1.55 Billion | €5.55 Billion | €1.42 Billion | ▲ +42.5% |
| 2017 | 0.20x | €1.45 Billion | €7.38 Billion | €1.39 Billion | ▼ -66.5% |
| 2016 | 0.59x | €4.59 Billion | €7.84 Billion | €2.08 Billion | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow